Jacek L. Mostwin, M.D., D. Phil. (Oxon), Medical Editor
Dr. Mostwin, a urological surgeon at Johns Hopkins, maintains a busy medical practice focusing on prostate cancer. He has performed more than 2,300 radical prostatectomies over the years. Among his major research interests are urinary continence issues and bladder function. Most of Dr. Mostwin's scientific publications have dealt with lower urinary tract problems.

We have assembled a prestigious medical advisory board comprised of faculty members at Johns Hopkins to provide you with information that can help prevent your quality of life from diminishing even if you do suffer from a prostate disorder.

Alan W. Partin, M.D., Ph.D.
is a renowned surgeon, researcher, and teacher whose work has influenced urological advances. Dr. Partin, Professor and Director of the James Buchanan Brady Urological Institute at Johns Hopkins, has both a basic science and clinical interest in prognosis prediction for men with prostate cancer. He is a dedicated scientist. Over the years, he has focused his scientific attention on development and testing of new and existing methods for predicting the aggressiveness of prostate cancers so that rational treatment decisions can be made by both patients and physicians.
The Partin tables, the diagnostic prostate cancer nomograms that Dr. Partin developed in 1993, now help prostate cancer patients the world over get an accurate prediction of their likelihood of being cured.

The physicians and researchers at the Johns Hopkins Brady Urological Institute aspire to provide the best medical care for patients through world-class medical practice, research and education.

Under the direction of chairman Dr. Alan Partin, the clinical facility is the world leader in treating prostate cancer, benign prostate hyperplasia, erectile dysfunction, incontinence and bladder dysfunction.

The research faculty, under the guidance of Dr. Robert H. Getzenberg, is renowned for breakthrough research in areas ranging from tumor suppressors and gene therapy to cell adhesion molecules and tumor markers.

A Personal Letter from Dr. Mostwin, which reviews critical prostate developments of the past few weeks. Treatment strategies. Early intervention options. New clinical trials. Reports from urological conferences that are helping to improve and prolong men’s lives.

In-Depth Reports give you the latest information about everything from new medications and preventive measures to dietary guidelines and minimally invasive procedures. Informative articles from leading prostate experts. No sensationalism. No hype. No hard-to-decipher medical jargon — just the facts you need to make better-informed health decisions.

Some of The Prostate Bulletin issues also include:

Grand Rounds: readers pose detailed questions about difficult health care decisions — and get detailed answers from top Hopkins urology specialists. The Bulletin helps you recognize early warning signs… communicate more effectively with your physician… understand your options.

Evaluate The Johns Hopkins Prostate Bulletin Prostate Cancer Review 2007 on a risk-FREE basis. If you're dissatisfied in any way, contact Customer Service and you'll receive a prompt refund of the entire cost, no questions asked.

Don't miss out on The Prostate Bulletin's Prostate Cancer Review 2007.
Order today

The Johns Hopkins Prostate Bulletin
Prostate Cancer Review 2007:
Can you afford to miss it?

For nearly a decade, the specialists at Johns Hopkins' James Buchanan Brady Urological Institute have been bringing you the latest news and most cutting-edge treatments for prostate cancer, BPH and prostatitis in The Johns Hopkins Prostate Bulletin.

In The Prostate Cancer Review 2007 issue, Dr. Jacek Mostwin and seven other world-renowned experts in their respective prostate cancer specialties give you a thorough overview of our progress in our battle against prostate cancer.

In the The Prostate Cancer Review 2007, they also outline for you the most promising new treatments you need to know about if you have been diagnosed with prostate cancer.

Those who already subscribe to The Johns Hopkins Prostate Bulletin will have already received this Spring 2007 Prostate Cancer Review issue (March 23, 2007), but countless more subscribers and visitors to this website missed out on this crucial health information once all the printed issues sold out.

Due to the overwhelming demand for The Prostate Cancer Review 2007 issue, thanks to this special offer, you can now get the instant PDF digital download edition for half-price.

That's right, you'll get 48 pages of invaluable prostate information direct from Hopkins' expert panel of specialists at Johns Hopkins, ranked America's #1 Medical Center and #1 Urology Center for 19 consecutive years.

Just look at what you'll get in The Prostate Cancer Review 2007 issue:

TABLE OF CONTENTS
Spring, 2007

Letter from Doctor Mostwin:

• New BPH Biomarker
  
• Until Next Time: A Preview of the American Urological Association Conference
  

Prostate Cancer Review 2007:

• Where We Are, Where We Are Going (Jacek L. Mostwin, M.D.)
  
• Prostate Cancer: Looking Back, Looking Forward (Alan W. Partin, M.D., Ph.D.)
  
• Treating the Prostate (Patrick C. Walsh, M.D.)
  
• Minimally-Invasive Radical Prostatectomy (Christian C. Pavlovich, M.D.)
  
• Radiation Therapy For Prostate Cancer (Theodore L. DeWeese, M.D.)
  
• Advanced Prostate Cancer Therapies (Michael A. Carducci, M.D.)
  
• The Molecular World Of Prostate Cancer (William G. Nelson, M.D., Ph.D.)
  
• Image-Guided Intervention For Prostate Cancer (Dan Stoianovici, Ph.D.)
  

In no other Prostate Bulletin issue will you find such an array of experts all focused on the latest breakthroughs on prostate cancer:

• its prevention
  
• diagnosis
  
• most successful treatments
  
• most promising cutting-edge therapies
  
• clinical trials
  
• further resources
   ...and more.

SAVE 50%

This wealth of information is available to your right now as an instant digital download, and at 50% off the list price.

Normally, a subscription to the quarterly Johns Hopkins Prostate Bulletin is priced at $199 per year for 4 issues, sent out in the post via Priority Mail. That's $49.95 per issue.

But for a limited time only, you can get this digital PDF download edition of The Prostate Cancer Review 2007 from The Johns Hopkins Prostate Bulletin for $49.95 only $24.95.

Why are we making this offer? Because we've had so many requests for The Prostate Cancer Review 2007 (first published March 23, 2007) from men who want the most expert, reliable information on prostate cancer, written in clear English.

This is news you can use as you work with your doctor to stay as informed and proactive as possible about your prostate health. You will discover all that we currently know about prostate cancer, its prevention, treatment, and cure. What emerging medications and technologies are of greatest interest for eradicating prostate cancer. The latest news on laparoscopic and robotic radical prostatectomy. The newest diagnostic tests. And whether you are eligible for any new or ongoing clinical trials.

All of the Johns Hopkins prostate publications are designed with YOU in mind, the busy person looking for the most comprehensive answers to your many questions about prostate cancer, from the world's leading experts.

This kind of cutting-edge information published in The Prostate Bulletin has simply been inaccessible to the average person, hidden in obscure medical journals or covered incompletely in minuscule articles in the back of the daily newspaper or worse still, sensationalized on the 6 o'clock news. This kind of breakthrough research, study findings, and clinical trials are so new in some instances, that even your busy doctor might not have ready access to this up-to-the-minute research in this highly specialized field.

As the nation's leading center for prostate care and research, Johns Hopkins' James Buchanan Brady Urological Institute is in a unique position to evaluate and disseminate the very latest information concerning advances in prostate treatment, reporting on their own research, and surveying the most promising findings from studies all over the globe. The Prostate Cancer Review 2007 provides 48 pages of detailed information direct from the doctors and researchers on the front line in the battle against prostate cancer.

Once you download The Prostate Cancer Review 2007 as a PDF file, you can start reading it immediately. You'll be able to discuss what you learn with your doctor and loved ones, and apply all you learn at once, to help you make the most informed decisions about your health to prevent or treat prostate cancer.

The Prostate Cancer Review 2007 will help you take control of your health, secure in the knowledge that your information is coming from the most trusted name in the world in successful prostate cancer treatment.

And as always, your purchase is completely RISK-FREE. The Prostate Cancer Review 2007 comes with a full 100% money-back guarantee. If you're not satsified with The Prostate Cancer Review 2007 issue, simply contact us within 30 days for a full refund.

Don't hesitate. Take advantage of this RISK-FREE offer now.

Yes, I need the Prostate Cancer Review 2007 as a PDF download

---

You can use your Mastercard and Visa credit/debit cards at this site.

This is a secure shopping site.
But if your prefer to place your order over the phone, or have any further questions, please contact:
Customer Service:
Inside US and Canada: 1-212-792-5417
Hours: M to F - 9AM to 9PM EST/EDT
Sat & Sun - 9AM TO 6PM EST/EDT
Email: customerservice@johnshopkinshealthalerts.com